ByDon MillerNovember 26, 2015Biomarin Pharmaceutical’s Kyndrisa was not enough to convince the FDA of its efficacyHealth A drug for treating Duchene Muscular Dystrophy has been deemed unsatisfactory in action by the FDA. Both Parent…
